Mathieu Bignon
Overview
Explore the profile of Mathieu Bignon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
67
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Roule V, Rebouh I, Lemaitre A, Sabatier R, Blanchart K, Briet C, et al.
Sci Rep
. 2022 Apr;
12(1):5967.
PMID: 35395869
Wait times are associated with mortality on waiting list for transcatheter aortic valve replacement (TAVR). Whether longer wait times are associated with long term mortality after successful TAVR remains unassessed....
2.
Roule V, Rebouh I, Roupie E, Malcor G, Bignon M, Trotel J, et al.
J Emerg Med
. 2021 Dec;
62(2):240-249.
PMID: 34955318
Background: Early initiation of a new P2Y12 inhibitor in ST-elevation myocardial infarction (STEMI) patients prior to primary percutaneous coronary intervention (PCI) is recommended over clopidogrel. However, comparative data remain limited,...
3.
Blanchart K, Heudel T, Ardouin P, Lemaitre A, Briet C, Bignon M, et al.
Clin Cardiol
. 2021 Jun;
44(8):1080-1088.
PMID: 34114653
Objectives: We sought to investigate the safety and potential benefit of administrating glycoprotein IIb-IIIa inhibitors (GPIs) on top of more potent P2Y12 inhibitors. Background: A number of clinical trials, performed...
4.
Roule V, Lemaitre A, Pommier W, Bignon M, Sabatier R, Blanchart K, et al.
Age Ageing
. 2021 Mar;
50(4):1102-1107.
PMID: 33755049
Background: older patients undergoing percutaneous coronary intervention (PCI) represent a growing population sharing both a high ischemic and bleeding risk. Dual antiplatelet therapy (DAPT) reduces the incidence of thrombotic events...
5.
Roule V, Rebouh I, Lemaitre A, Bignon M, Ardouin P, Sabatier R, et al.
J Interv Cardiol
. 2020 Jun;
2020:4817239.
PMID: 32581660
Objectives: We aimed to assess the quality of optical frequency domain imaging (OFDI) of the left main (LM) arterial wall and describe and analyse potential artefacts in this setting. Background:...
6.
Roule V, Schwob L, Briet C, Lemaitre A, Bignon M, Ardouin P, et al.
J Thromb Thrombolysis
. 2020 Apr;
50(4):858-866.
PMID: 32306289
We compared residual platelet reactivity and post PCI atherothrombotic burden using OFDI in patients successfully treated by primary PCI versus pharmacoinvasive approach (PI) defined as PCI after successful pre-hospital fibrinolysis....
7.
Roule V, Verdier L, Blanchart K, Ardouin P, Lemaitre A, Bignon M, et al.
BMC Cardiovasc Disord
. 2020 Feb;
20(1):38.
PMID: 32000685
Background: Patients with cancer admitted for an acute coronary syndrome (ACS) and/or percutaneous coronary intervention (PCI) represent a growing and high-risk population. The influence of co-existing cancer on mortality remains...
8.
Roule V, Schwob L, Lemaitre A, Bignon M, Ardouin P, Sabatier R, et al.
Catheter Cardiovasc Interv
. 2019 Aug;
96(1):91-97.
PMID: 31410965
Objectives: We aimed to assess the relationship between residual in-stent atherothrombotic burden (ATB) after primary percutaneous coronary intervention (PCI) measured by optical frequency domain imaging (OFDI) using different measurement methods...
9.
Roule V, Heudel T, Lemaitre A, Bignon M, Ardouin P, Sabatier R, et al.
Eur Heart J Acute Cardiovasc Care
. 2019 Aug;
10(2):184–189.
PMID: 31402681
Background: The evidence of a clinical benefit of P2Y12 inhibitor pre-treatment in primary percutaneous coronary intervention (PCI) and the relation between the level of platelet inhibition and myocardial reperfusion with...
10.
Beygui F, Lemaitre A, Bignon M, Wain-Hobson J, Briet C, Ardouin P, et al.
Catheter Cardiovasc Interv
. 2019 Aug;
95(6):1094-1101.
PMID: 31402567
Objectives: To compare three FFR technologies: the electric-sensor Pressurewire® (P), the optic-sensor Comet® (C) guidewire, and the optic-sensor Navvus® (N) microcatheter. Background: Different technologies are used to measure fractional flow...